CD1A/B Rabbit Polyclonal Antibody
CD1A/B Rabbit Polyclonal Antibody
![]() CD1A/B Polyclonal Antibody |
|||
ABP58042-01ml | Abbkine | 0.1ml | 346.8 EUR |
Description: A polyclonal antibody for detection of CD1A/B from Human. This CD1A/B antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD1A/B protein at amino acid sequence of 220-270 |
|||
![]() CD1A/B Polyclonal Antibody |
|||
ABP58042-02ml | Abbkine | 0.2ml | 496.8 EUR |
Description: A polyclonal antibody for detection of CD1A/B from Human. This CD1A/B antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human CD1A/B protein at amino acid sequence of 220-270 |
|||
![]() CD1A/B Polyclonal Antibody |
|||
ES8784-100ul | ELK Biotech | 100ul | 334.8 EUR |
Description: A Rabbit Polyclonal antibody against CD1A/B from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
![]() CD1A/B Polyclonal Antibody |
|||
ES8784-50ul | ELK Biotech | 50ul | 248.4 EUR |
Description: A Rabbit Polyclonal antibody against CD1A/B from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
![]() Anti-CD1A/B antibody |
|||
STJ98989 | St John's Laboratory | 200 µl | 236.4 EUR |
Description: Rabbit polyclonal to CD1A/B. |
|||
![]() CD1A Rabbit pAb |
|||
A5722-100ul | Abclonal | 100 ul | 369.6 EUR |
![]() CD1A Rabbit pAb |
|||
A5722-200ul | Abclonal | 200 ul | 550.8 EUR |
![]() CD1A Rabbit pAb |
|||
A5722-20ul | Abclonal | 20 ul | 219.6 EUR |
![]() CD1A Rabbit pAb |
|||
A5722-50ul | Abclonal | 50 ul | 267.6 EUR |
![]() CD1A antibody |
|||
70R-16257 | Fitzgerald | 50 ul | 522 EUR |
Description: Rabbit polyclonal CD1A antibody |
|||
![]() CD1a Antibody |
|||
49610-100ul | SAB | 100ul | 399.6 EUR |
![]() CD1a Antibody |
|||
49610-50ul | SAB | 50ul | 286.8 EUR |
![]() CD1A Antibody |
|||
32993-100ul | SAB | 100ul | 302.4 EUR |
![]() CD1a antibody |
|||
10R-6325 | Fitzgerald | 100 ug | 249.6 EUR |
Description: Mouse monoclonal CD1a antibody |
|||
![]() CD1A antibody |
|||
10R-7787 | Fitzgerald | 500 ug | 678 EUR |
Description: Mouse monoclonal CD1A antibody |
|||
![]() CD1A antibody |
|||
10R-10717 | Fitzgerald | 100 ug | 418.8 EUR |
Description: Mouse monoclonal CD1A antibody |
|||
![]() CD1A antibody |
|||
10R-10739 | Fitzgerald | 100 ug | 418.8 EUR |
Description: Mouse monoclonal CD1A antibody |
|||
![]() CD1A Antibody |
|||
BF0122 | Affbiotech | 200ul | 540 EUR |
![]() CD1A Antibody |
|||
1-CSB-PA789186 | Cusabio |
|
|
Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;ELISA:1:2000-1:5000, WB:1:500-1:2000 |
|||
![]() CD1a Antibody |
|||
DF13391 | Affbiotech | 100ul | 420 EUR |
![]() CD1A Antibody |
|||
1-CSB-PA004889ESR1HU | Cusabio |
|
|
Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC; Recommended dilution: IHC:1:20-1:200 |
|||
![]() CD1A Antibody |
|||
1-CSB-PA004889ESR2HU | Cusabio |
|
|
Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:500-1:2000, IHC:1:20-1:200 |
|||
![]() CD1A Antibody |
|||
1-CSB-PA004889GA01HU | Cusabio |
|
|
Description: A polyclonal antibody against CD1A. Recognizes CD1A from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IF |
|||
![]() CD1a Antibody |
|||
R30975 | NSJ Bioreagents | 100 ug | 419 EUR |
![]() CD1a Antibody |
|||
F53637-0.1ML | NSJ Bioreagents | 0.1 ml | 379 EUR |
![]() CD1a Antibody |
|||
F43045-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
![]() CD1a Antibody |
|||
F43045-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
![]() CD1a Antibody |
|||
V8193-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V8193-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V8193SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2948-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2948-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2948SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2949-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CD1a is an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells. [UniProt] |
|||
![]() CD1a Antibody |
|||
V2949-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: CD1a is an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells. [UniProt] |
|||
![]() CD1a Antibody |
|||
V2949SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CD1a is an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells. [UniProt] |
|||
![]() CD1a Antibody |
|||
V3253-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V3253-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V3253SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V3541-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V3541-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V3541IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V3541SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. Anti-CD1a labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibodies against TTF-1 and CD5, anti-CD1a is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. Anti-CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V7012-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V7012-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V7012SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V7231-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin. |
|||
![]() CD1a Antibody |
|||
V7231-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin. |
|||
![]() CD1a Antibody |
|||
V7231IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin. |
|||
![]() CD1a Antibody |
|||
V7231SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein expressed in association with Beta-2 microglobulin. |
|||
![]() CD1a Antibody |
|||
V7376-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V7376-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V7376IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V7376SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2025-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2025-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2025IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2025SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict Tcell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since it is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. CD1a antibody is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2026-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2026-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2026IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody |
|||
V2026SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a |
|||
1AA-100T | ImmunoStep | 100 test | 418.8 EUR |
![]() CD1a |
|||
1AB-01MG | ImmunoStep | 100 test | 340.8 EUR |
![]() CD1a |
|||
1ACFB-100T | ImmunoStep | 100 test | 465.6 EUR |
![]() CD1a |
|||
1AF-100T | ImmunoStep | 100 test | 356.4 EUR |
![]() CD1a |
|||
1APE-100T | ImmunoStep | 100 test | 418.8 EUR |
![]() CD1a |
|||
1APPC5.5-100T | ImmunoStep | 100 test | 434.4 EUR |
![]() CD1a |
|||
1APU-01MG | ImmunoStep | 0,1 mg | 262.8 EUR |
![]() CD1A |
|||
PR27288 | Neuromics | 5 ug | 381.6 EUR |
![]() Polyclonal CD1A antibody - C-terminal region |
|||
APR01536G | Leading Biology | 0.05mg | 633.6 EUR |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CD1A - C-terminal region. This antibody is tested and proven to work in the following applications: |
|||
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
20-abx159382 | Abbexa |
|
|
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx139080-01mg | Abbexa | 0.1 mg | 444 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
20-abx141314 | Abbexa |
|
|
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx146226-100ug | Abbexa | 100 ug | 469.2 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
20-abx004375 | Abbexa |
|
|
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
20-abx111464 | Abbexa |
|
|
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx010518-100ul | Abbexa | 100 ul | 493.2 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx015794-100ul | Abbexa | 100 ul | 493.2 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx027451-400ul | Abbexa | 400 ul | 627.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx027451-80l | Abbexa | 80 µl | 343.2 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx200001-100ug | Abbexa | 100 ug | 393.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
20-abx320639 | Abbexa |
|
|
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
20-abx322311 | Abbexa |
|
|
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx415367-01mg | Abbexa | 0.1 mg | 543.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx415541-02mg | Abbexa | 0.2 mg | 678 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx415548-01mg | Abbexa | 0.1 mg | 526.8 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx231434-100ug | Abbexa | 100 ug | 610.8 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
abx231435-100ug | Abbexa | 100 ug | 577.2 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody |
|||
20-abx211317 | Abbexa |
|
|
![]() CD1a antibody (FITC) |
|||
61R-1030 | Fitzgerald | 100 tests | 379.2 EUR |
Description: Mouse monoclonal CD1a antibody (FITC) |
|||
![]() CD1a(O10) Antibody |
|||
BNC040667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC040667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC041034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC041034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC050667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC050667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCAP0667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCAP0667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCAP1034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCAP1034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCB0667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), Biotin conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCB0667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), Biotin conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCB1034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), Biotin conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCB1034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), Biotin conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCP0667-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against CD1a(O10), PerCP conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCP1034-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against CD1a(66IIC7), PerCP conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCR0667-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against CD1a(O10), RPE conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCR1034-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against CD1a(66IIC7), RPE conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC940667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF594 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC940667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF594 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC941034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF594 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC941034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF594 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCA0667-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against CD1a(O10), APC conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCA1034-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against CD1a(66IIC7), APC conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC810667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF680R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC810667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF680R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC811034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF680R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC811034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF680R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNUB0667-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against CD1a(O10), Concentration: 0.2mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNUB0667-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against CD1a(O10), Concentration: 0.2mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNUB1034-100 | Biotium | 100uL | 250.8 EUR |
Description: Primary antibody against CD1a(66IIC7), Concentration: 0.2mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNUB1034-500 | Biotium | 500uL | 549.6 EUR |
Description: Primary antibody against CD1a(66IIC7), Concentration: 0.2mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCH0667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNCH0667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCH1034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNCH1034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC880667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF488A conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC880667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF488A conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC881034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF488A conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC881034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF488A conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a Conjugated Antibody |
|||
C49610 | SAB | 100ul | 476.4 EUR |
![]() CD1a(O10) Antibody |
|||
BNC680667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF568 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC680667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF568 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC681034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF568 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC681034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF568 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC470667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF647 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC470667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF647 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC471034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF647 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC471034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF647 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC400667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF640R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC400667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF640R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC401034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF640R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC401034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF640R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC430667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF543 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC430667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF543 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC431034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF543 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC431034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF543 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC550667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF555 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC550667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF555 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC551034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF555 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC551034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF555 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC610667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF660R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC610667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF660R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC611034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF660R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC611034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF660R conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC800667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF680 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC800667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF680 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC801034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF680 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC801034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF680 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC051034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC051034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC701034-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF770 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNC701034-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(66IIC7), CF770 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC700667-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(O10), CF770 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNC700667-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(O10), CF770 conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(66IIC7) Antibody |
|||
BNUM1034-50 | Biotium | 50uL | 474 EUR |
Description: Primary antibody against CD1a(66IIC7), 1mg/mL |
|||
![]() CD1a(O10) Antibody |
|||
BNUM0667-50 | Biotium | 50uL | 474 EUR |
Description: Primary antibody against CD1a(O10), 1mg/mL |
|||
![]() Anti-CD1A antibody |
|||
PAab01434 | Lifescience Market | 100 ug | 463.2 EUR |
![]() anti- CD1A antibody |
|||
FNab01434 | FN Test | 100µg | 658.5 EUR |
Description: Antibody raised against CD1A |
|||
![]() anti- CD1A antibody |
|||
FNab01435 | FN Test | 100µg | 606.3 EUR |
Description: Antibody raised against CD1A |
|||
![]() Anti-CD1a Antibody |
|||
PA1875 | BosterBio | 100ug/vial | 352.8 EUR |
![]() Anti-CD1A antibody |
|||
STJ97912 | St John's Laboratory | 100 µl | 280.8 EUR |
Description: Mouse monoclonal to CD1A. |
|||
![]() Anti-CD1A antibody |
|||
STJ97913 | St John's Laboratory | 100 µl | 280.8 EUR |
Description: Mouse monoclonal to CD1A. |
|||
![]() Anti-CD1A antibody |
|||
STJ28289 | St John's Laboratory | 100 µl | 332.4 EUR |
Description: This gene encodes a member of the CD1 family of transmembrane glycoproteins, which are structurally related to the major histocompatibility complex (MHC) proteins and form heterodimers with beta-2-microglobulin. The CD1 proteins mediate the presentation of primarily lipid and glycolipid antigens of self or microbial origin to T cells. The human genome contains five CD1 family genes organized in a cluster on chromosome 1. The CD1 family members are thought to differ in their cellular localization and specificity for particular lipid ligands. The protein encoded by this gene localizes to the plasma membrane and to recycling vesicles of the early endocytic system. Alternative splicing results in multiple transcript variants. |
|||
![]() Anti-CD1a antibody |
|||
STJ16100021 | St John's Laboratory | 100 µg | 424.8 EUR |
![]() Anti-CD1a antibody |
|||
STJ16101092 | St John's Laboratory | 100 µg | 424.8 EUR |
![]() Anti-CD1a antibody |
|||
STJ180042 | St John's Laboratory | 0.1 ml | 254.4 EUR |
![]() Anti-CD1a antibody |
|||
STJ190010 | St John's Laboratory | 200 µl | 236.4 EUR |
Description: Unconjugated Mouse monoclonal to CD1a (AS1A30) |
|||
![]() CD1a Antibody Cocktail |
|||
V2027-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody Cocktail |
|||
V2027-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody Cocktail |
|||
V2027IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() CD1a Antibody Cocktail |
|||
V2027SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
Description: At least five CD1 genes (CD1a, b, c, d, and e) are identified. CD1 proteins have been demonstrated to restrict T cell response to non-peptide lipid and glycolipid antigens and play a role in non-classical antigen presentation. CD1a is a non-polymorphic MHC Class 1 related cell surface glycoprotein, expressed in association with Beta-2 microglobulin. CD1a antibody labels Langerhans cell histiocytosis (Histiocytosis X), extranodal histiocytic sarcoma, a subset of T-lymphoblastic lymphoma/leukemia, and interdigitating dendritic cell sarcoma of the lymph node. When combined with antibody against TTF-1 and CD5, CD1a antibody is useful in distinguishing between pulmonary and thymic neoplasms since CD1a is consistently expressed in thymic lymphocytes in both typical and atypical thymomas, but only focally in 1/6 of thymic carcinomas and not in lymphocytes in pulmonary neoplasms. antibody to CD1a is reported to be a new marker for perivascular epithelial cell tumor (PEComa). |
|||
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (PE) |
|||
abx139081-100tests | Abbexa | 100 tests | 577.2 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (APC) |
|||
abx139082-100tests | Abbexa | 100 tests | 577.2 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) |
|||
abx139083-100tests | Abbexa | 100 tests | 510 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) |
|||
abx200002-100tests | Abbexa | 100 tests | 477.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (PE) |
|||
abx200003-100tests | Abbexa | 100 tests | 543.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (APC) |
|||
abx200004-100tests | Abbexa | 100 tests | 543.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (PerCP) |
|||
abx200005-100tests | Abbexa | 100 tests | 543.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (Biotin) |
|||
abx200006-100ug | Abbexa | 100 ug | 460.8 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) |
|||
abx415366-01mg | Abbexa | 0.1 mg | 777.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (RPE) |
|||
abx415368-01mg | Abbexa | 0.1 mg | 861.6 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (FITC) |
|||
abx415547-01mg | Abbexa | 0.1 mg | 610.8 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (RPE) |
|||
abx415549-100tests | Abbexa | 100 tests | 710.4 EUR |
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (RPE) |
|||
abx415550-25tests | Abbexa | 25 tests | 376.8 EUR |
![]() Fmoc-b,b-diphenyl-Ala-OH |
|||
B-2725.0250 | Bachem | 250.0mg | 166.8 EUR |
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6] |
|||
![]() Fmoc-b,b-diphenyl-Ala-OH |
|||
B-2725.1000 | Bachem | 1.0g | 428.4 EUR |
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6] |
|||
![]() Fmoc-b,b-diphenyl-Ala-OH |
|||
B-2725.5000 | Bachem | 5.0g | 1603.2 EUR |
Description: Sum Formula: C30H25NO4; CAS# [201484-50-6] |
|||
![]() CD1A siRNA |
|||
20-abx910942 | Abbexa |
|
|
![]() Anti-CD1a |
|||
DB-071-0.1 | DB Biotech | 100 μl | 294 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
|||
![]() Anti-CD1a |
|||
DB-071-0.2 | DB Biotech | 200 μl | 416.4 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
|||
![]() Anti-CD1a |
|||
DB-071-0.5 | DB Biotech | 500 μl | 540 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
|||
![]() Anti-CD1a |
|||
DB-071-1 | DB Biotech | 1 ml | 867.6 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; concentrated |
|||
![]() Anti-CD1a |
|||
DB-071-RTU-15 | DB Biotech | 15 ml | 496.8 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
![]() Anti-CD1a |
|||
DB-071-RTU-7 | DB Biotech | 7 ml | 321.6 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
![]() Anti-CD1a |
|||
DB071RTU-15 | DB Biotech | 15 ml | 496.8 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
![]() Anti-CD1a |
|||
DB071RTU-7 | DB Biotech | 7 ml | 321.6 EUR |
Description: rabbit monospecific clonal antibodies for ihc-p application; prediluted (ready to use) |
|||
![]() anti-CD1a |
|||
YF-PA23381 | Abfrontier | 50 ul | 400.8 EUR |
Description: Mouse polyclonal to CD1a |
|||
![]() anti-CD1A |
|||
YF-PA27188 | Abfrontier | 50 ug | 435.6 EUR |
Description: Mouse polyclonal to CD1A |
|||
![]() T-cell Surface Glycoprotein CD1a (CD1A) Antibody (CF-Blue) |
|||
abx200007-100tests | Abbexa | 100 tests | 577.2 EUR |
![]() CD1A (T6, LEU6) Antibody |
|||
20-abx137038 | Abbexa |
|
|
![]() CD1a(CB-T6) Antibody |
|||
BNC040157-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(CB-T6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(CB-T6) Antibody |
|||
BNC040157-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(CB-T6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(C1A/711) Antibody |
|||
BNC040711-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(C1A/711), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(C1A/711) Antibody |
|||
BNC040711-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(C1A/711), CF405S conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(CB-T6) Antibody |
|||
BNC050157-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(CB-T6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(CB-T6) Antibody |
|||
BNC050157-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(CB-T6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(C1A/711) Antibody |
|||
BNC050711-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(C1A/711), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(C1A/711) Antibody |
|||
BNC050711-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(C1A/711), CF405M conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(CB-T6) Antibody |
|||
BNCAP0157-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(CB-T6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(CB-T6) Antibody |
|||
BNCAP0157-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(CB-T6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(C1A/711) Antibody |
|||
BNCAP0711-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(C1A/711), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(C1A/711) Antibody |
|||
BNCAP0711-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against CD1a(C1A/711), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
![]() CD1a(CB-T6) Antibody |
|||
BNCB0157-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against CD1a(CB-T6), Biotin conjugate, Concentration: 0.1mg/mL |
CD1A/B Rabbit Polyclonal Antibody